Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES, Ferrer A, Mangaonkar AA, Khan SP, Kohorst MA, Joshi AY, Hogan WJ, Olteanu H, Moyer AM, Al-Kali A, Tefferi A, Chen D, Wudhikarn K, Go R, Viswanatha D, He R, Ketterling R, Nguyen PL, Oliveira JL, Gangat N, Lasho T, Patnaik MM. Martin ES, et al. Among authors: moyer am. Am J Hematol. 2021 Nov 1;96(11):1450-1460. doi: 10.1002/ajh.26321. Epub 2021 Aug 27. Am J Hematol. 2021. PMID: 34390506 Free article.
Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseases.
Moyer AM, Walker DL, Avula R, Lapid MI, Kung S, Bryant SC, Edwards KK, Black JL, Karpyak VM, Shinozaki G, Jowsey-Gregoire SG, Ehlers SL, Romanowicz M, Litzow MR, Hogan WJ, Rundell JR, Hooten WM, Baudhuin LM. Moyer AM, et al. Genet Test Mol Biomarkers. 2015 Mar;19(3):115-23. doi: 10.1089/gtmb.2014.0250. Epub 2015 Feb 11. Genet Test Mol Biomarkers. 2015. PMID: 25671637
Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK, Moyer AM, Goodenberger ML, Keeney GL, Carter JM, Bakkum-Gamez JN. Schoolmeester JK, et al. Among authors: moyer am. Hum Pathol. 2017 Dec;70:14-26. doi: 10.1016/j.humpath.2017.06.018. Epub 2017 Jul 12. Hum Pathol. 2017. PMID: 28709830
Does Transfusion of Red Blood Cells Impact Germline Genetic Test Results?
DiGuardo MA, Kester SJ, Mahaffey VJ, Hammel SA, Heaser KK, Hofich CD, Tauscher CD, Kerr SE, Oliveira JL, Jacob EK, Moyer AM. DiGuardo MA, et al. Among authors: moyer am. J Pers Med. 2020 Dec 9;10(4):268. doi: 10.3390/jpm10040268. J Pers Med. 2020. PMID: 33316904 Free PMC article.
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Ellingson MS, Hart SN, Kalari KR, Suman V, Schahl KA, Dockter TJ, Felten SJ, Sinnwell JP, Thompson KJ, Tang X, Vedell PT, Barman P, Sicotte H, Eckel-Passow JE, Northfelt DW, Gray RJ, McLaughlin SA, Moreno-Aspitia A, Ingle JN, Moyer AM, Visscher DW, Jones K, Conners A, McDonough M, Wieben ED, Wang L, Weinshilboum R, Boughey JC, Goetz MP. Ellingson MS, et al. Among authors: moyer am. Breast Cancer Res Treat. 2015 Sep;153(2):435-43. doi: 10.1007/s10549-015-3545-6. Epub 2015 Aug 22. Breast Cancer Res Treat. 2015. PMID: 26296701 Free PMC article.
Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET, Ragan AK, Oyen LJ, Vitek CR, Aoudia SL, Ragab AK, Fee-Schroeder KC, Black JL, Moyer AM, Nicholson WT, Shrestha S, McAllister TM, Sinnwell JP, Faubion SS, Lazaridis KN. Matey ET, et al. Among authors: moyer am. Pharmacogenomics J. 2022 Feb;22(1):69-74. doi: 10.1038/s41397-021-00258-0. Epub 2021 Oct 20. Pharmacogenomics J. 2022. PMID: 34671112
181 results